![]() |
同义名 : | MPTP hydrochloride |
CAS号 : | 23007-85-4 | |
货号 : | A211071 | |
分子式 : | C12H16ClN | |
纯度 : | 99+% | |
分子量 : | 209.72 | |
MDL号 : | MFCD00012790 | |
存储条件: |
Pure form Sealed in dry,2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Parkinson’s disease (PD) is characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN). MPTP is a neurotoxin that can induce symptoms similar to those observed in PD in humans, nonhuman primates, and mice. In addition, MPTP induces selective loss of dopaminergic neurons in mice SN[3]. Mice in the MPTP group were intraperitoneally injected with 20 mg/kg MPTP hydrochloride dissolved in saline, with four injections at 3-hour intervals over a period of 1 day. The number of tyrosine hydroxylase-immunoreactive neurons in the MPTP group was significantly lower than in the normal group (P < 0.05), indicating successful establishment of the Parkinson's disease model. The changes in thioredoxin reductase 1 protein expression in the midbrain 7 days after the last injection of MPTP were detected. The MPTP-treated mice showed a 40% decrease in thioredoxin reductase 1 protein level compared with the normal mice (P < 0.05). Moreover, there was a pronounced reduction in thioredoxin reductase 1 mRNA level in MPTP-treated mice compared with normal mice (P < 0.05)[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.77mL 0.95mL 0.48mL |
23.84mL 4.77mL 2.38mL |
47.68mL 9.54mL 4.77mL |
参考文献 |
---|